BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7561976)

  • 1. Flexible matching of test ligands to a 3D pharmacophore using a molecular superposition force field: comparison of predicted and experimental conformations of inhibitors of three enzymes.
    McMartin C; Bohacek RS
    J Comput Aided Mol Des; 1995 Jun; 9(3):237-50. PubMed ID: 7561976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QXP: powerful, rapid computer algorithms for structure-based drug design.
    McMartin C; Bohacek RS
    J Comput Aided Mol Des; 1997 Jul; 11(4):333-44. PubMed ID: 9334900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different approaches toward an automatic structural alignment of drug molecules: applications to sterol mimics, thrombin and thermolysin inhibitors.
    Klebe G; Mietzner T; Weber F
    J Comput Aided Mol Des; 1994 Dec; 8(6):751-78. PubMed ID: 7738608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based thermodynamic design of peptide ligands: application to peptide inhibitors of the aspartic protease endothiapepsin.
    Luque I; Gómez J; Semo N; Freire E
    Proteins; 1998 Jan; 30(1):74-85. PubMed ID: 9443342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel method for the modelling of peptide ligands to their receptors.
    Singh J; Saldanha J; Thornton JM
    Protein Eng; 1991 Feb; 4(3):251-61. PubMed ID: 1857711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empirical free energy as a target function in docking and design: application to HIV-1 protease inhibitors.
    King BL; Vajda S; DeLisi C
    FEBS Lett; 1996 Apr; 384(1):87-91. PubMed ID: 8797810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming.
    Gehlhaar DK; Verkhivker GM; Rejto PA; Sherman CJ; Fogel DB; Fogel LJ; Freer ST
    Chem Biol; 1995 May; 2(5):317-24. PubMed ID: 9383433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The local minima method (LMM) of pharmacophore determination: a protocol for predicting the bioactive conformation of small, conformationally flexible molecules.
    Demeter DA; Weintraub HJ; Knittel JJ
    J Chem Inf Comput Sci; 1998; 38(6):1125-36. PubMed ID: 9845967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational analysis of TMC114, a novel HIV-1 protease inhibitor.
    Nivesanond K; Peeters A; Lamoen D; Van Alsenoy C
    J Chem Inf Model; 2008 Jan; 48(1):99-108. PubMed ID: 18173253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FLEXS: a method for fast flexible ligand superposition.
    Lemmen C; Lengauer T; Klebe G
    J Med Chem; 1998 Nov; 41(23):4502-20. PubMed ID: 9804690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional QSAR of human immunodeficiency virus (I) protease inhibitors. 1. A CoMFA study employing experimentally-determined alignment rules.
    Waller CL; Oprea TI; Giolitti A; Marshall GR
    J Med Chem; 1993 Dec; 36(26):4152-60. PubMed ID: 8277496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating Multiple Receptor Conformation Docking and Multi Dimensional QSAR for Enhancing Accuracy of Binding Affinity Prediction.
    Radhika V; Jaraf HA; Kanth SS; Vijjulatha M
    Curr Comput Aided Drug Des; 2017; 13(2):127-142. PubMed ID: 28103770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mean field model of ligand-protein interactions: implications for the structural assessment of human immunodeficiency virus type 1 protease complexes and receptor-specific binding.
    Verkhivker GM; Rejto PA
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):60-4. PubMed ID: 8552675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of ligand-receptor binding thermodynamics by free energy force field (FEFF) 3D-QSAR analysis: application to a set of peptidometic renin inhibitors.
    Tokarski JS; Hopfinger AJ
    J Chem Inf Comput Sci; 1997; 37(4):792-811. PubMed ID: 9254912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A semiempirical free energy force field with charge-based desolvation.
    Huey R; Morris GM; Olson AJ; Goodsell DS
    J Comput Chem; 2007 Apr; 28(6):1145-52. PubMed ID: 17274016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDS: flexible ligand and receptor docking with a continuum solvent model and soft-core energy function.
    Taylor RD; Jewsbury PJ; Essex JW
    J Comput Chem; 2003 Oct; 24(13):1637-56. PubMed ID: 12926007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refining the multiple protein structure pharmacophore method: consistency across three independent HIV-1 protease models.
    Meagher KL; Lerner MG; Carlson HA
    J Med Chem; 2006 Jun; 49(12):3478-84. PubMed ID: 16759090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fast and efficient method to generate biologically relevant conformations.
    Klebe G; Mietzner T
    J Comput Aided Mol Des; 1994 Oct; 8(5):583-606. PubMed ID: 7876902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo docking of oligopeptides to proteins.
    Caflisch A; Niederer P; Anliker M
    Proteins; 1992 Jul; 13(3):223-30. PubMed ID: 1603811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.